{
  "chunk_id": "V_iii_2_B_42",
  "content": "/>\nV.iii.2.B.4.d\n.\nMeniere’s Disease\nMeniere’s Disease (endolymphatic hydrops) is to be rated\nunder the criteria in\n38 CFR 4.87, DC 6205\nwhich consider frequency of attacks of symptoms including hearing loss (with or without tinnitus) and vertigo and cerebellar gait,\nor\nby assigning separate evaluations for hearing impairment (\n38 CFR 4.85, DC 6100\n), tinnitus (\n38 CFR 4.87, DC 6210\n), and vertigo (rating vertigo as a peripheral vestibular disorder under\n38 CFR 4.87, DC 6204\n).\nUse whichever approach results in a higher evaluation.\nDo not\nseparately assign an evaluation under\n38 CFR 4.87, DC 6205\nand a rating for hearing loss, tinnitus, or vertigo.\nReference\n:  For information on assessment of hearing impairment when evaluating Meniere’s Disease under\n38 CFR 4.87, DC 6205\n, see\nM21-1, Part V, Subpart iii, 2.B.2.l\n.",
  "title": "M21-1, Part V, Subpart iii, Chapter 2, Section B - Conditions of the Auditory System",
  "citation": "Part V, Subpart iii, Chapter 2, Section B",
  "source_url": "https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014464/M21-1-Part-V-Subpart-iii-Chapter-2-Section-B-Conditions-of-the-Auditory-System",
  "updated": "",
  "scraped_at": "2025-06-16T22:44:11.679803",
  "tags": [
    "m21-1"
  ]
}